Business Context and Reporting Period
Company: Processa Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date: December 5, 2017
Event: Regulation FD Disclosure regarding a corporate presentation delivered at the LDMicro 10th Annual Main Event in Los Angeles.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of presentation materials and does not contain audited or unaudited financial statements.
Material Changes
No material financial changes or operational updates are detailed within the text of this Form 8-K. The document references an attached presentation (Exhibit 99.1) for further details but does not summarize those contents.
Guidance, Outlook, and Risks
- Management Commentary: The Company disclaims any obligation to update the presentation materials in the future or to reflect events occurring after the date of this report.
- Legal Status: The information contained in the presentation is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
- Availability: The presentation materials are intended to be posted on the Company's Investor Relations website.
Key Facts for Investor Verification
- Verify the content of the attached Exhibit 99.1 (Corporate Presentation dated December 5, 2017) for specific business updates.
- Confirm the current status of the presentation materials on the Company's website (www.processapharma.com).
- Note that the presentation materials are forward-looking and the Company has explicitly disclaimed an obligation to update them.